Report Detail

Request for Sample of this report

Pharma & Healthcare Global Egg-Based Flu Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4561702
    • |
  • 21 October, 2023
    • |
  • Global
    • |
  • 101 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Egg-Based Flu Vaccines market size was valued at USD 7330.2 million in 2022 and is forecast to a readjusted size of USD 10170 million by 2029 with a CAGR of 4.8% during review period.
The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
The Global Info Research report includes an overview of the development of the Egg-Based Flu Vaccines industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Egg-Based Flu Vaccines.
Regionally, the report analyzes the Egg-Based Flu Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Egg-Based Flu Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Egg-Based Flu Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Egg-Based Flu Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Egg-Based Flu Vaccines market.
Regional Analysis: The report involves examining the Egg-Based Flu Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Egg-Based Flu Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Egg-Based Flu Vaccines:
Company Analysis: Report covers individual Egg-Based Flu Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Egg-Based Flu Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Egg-Based Flu Vaccines. It assesses the current state, advancements, and potential future developments in Egg-Based Flu Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Egg-Based Flu Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Egg-Based Flu Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Egg-Based Flu Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Egg-Based Flu Vaccines, with price, sales, revenue and global market share of Egg-Based Flu Vaccines from 2018 to 2023.
Chapter 3, the Egg-Based Flu Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Egg-Based Flu Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Egg-Based Flu Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Egg-Based Flu Vaccines.
Chapter 14 and 15, to describe Egg-Based Flu Vaccines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Egg-Based Flu Vaccines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Trivalent Influenza Vaccine
    • 1.3.3 Quadrivalent Influenza Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 6 Months to 3 Years
    • 1.4.3 > 3 Years
  • 1.5 Global Egg-Based Flu Vaccines Market Size & Forecast
    • 1.5.1 Global Egg-Based Flu Vaccines Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Egg-Based Flu Vaccines Sales Quantity (2018-2029)
    • 1.5.3 Global Egg-Based Flu Vaccines Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Egg-Based Flu Vaccines Product and Services
    • 2.1.4 Sanofi Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Egg-Based Flu Vaccines Product and Services
    • 2.2.4 CSL Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Egg-Based Flu Vaccines Product and Services
    • 2.3.4 GSK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Egg-Based Flu Vaccines Product and Services
    • 2.4.4 Viatris Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Egg-Based Flu Vaccines Product and Services
    • 2.5.4 AstraZeneca Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Egg-Based Flu Vaccines Product and Services
    • 2.6.4 Hualan Bio Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Changchun Institute of Biological
    • 2.7.1 Changchun Institute of Biological Details
    • 2.7.2 Changchun Institute of Biological Major Business
    • 2.7.3 Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
    • 2.7.4 Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.8 Sinovac
    • 2.8.1 Sinovac Details
    • 2.8.2 Sinovac Major Business
    • 2.8.3 Sinovac Egg-Based Flu Vaccines Product and Services
    • 2.8.4 Sinovac Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sinovac Recent Developments/Updates
  • 2.9 BCHT
    • 2.9.1 BCHT Details
    • 2.9.2 BCHT Major Business
    • 2.9.3 BCHT Egg-Based Flu Vaccines Product and Services
    • 2.9.4 BCHT Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BCHT Recent Developments/Updates
  • 2.10 Jiangsu GDK
    • 2.10.1 Jiangsu GDK Details
    • 2.10.2 Jiangsu GDK Major Business
    • 2.10.3 Jiangsu GDK Egg-Based Flu Vaccines Product and Services
    • 2.10.4 Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jiangsu GDK Recent Developments/Updates
  • 2.11 KM Biologics
    • 2.11.1 KM Biologics Details
    • 2.11.2 KM Biologics Major Business
    • 2.11.3 KM Biologics Egg-Based Flu Vaccines Product and Services
    • 2.11.4 KM Biologics Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Egg-Based Flu Vaccines by Manufacturer

  • 3.1 Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023)
  • 3.3 Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
  • 3.5 Egg-Based Flu Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Egg-Based Flu Vaccines Market: Region Footprint
    • 3.5.2 Egg-Based Flu Vaccines Market: Company Product Type Footprint
    • 3.5.3 Egg-Based Flu Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Egg-Based Flu Vaccines Market Size by Region
    • 4.1.1 Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
    • 4.1.3 Global Egg-Based Flu Vaccines Average Price by Region (2018-2029)
  • 4.2 North America Egg-Based Flu Vaccines Consumption Value (2018-2029)
  • 4.3 Europe Egg-Based Flu Vaccines Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029)
  • 4.5 South America Egg-Based Flu Vaccines Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Egg-Based Flu Vaccines Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 5.2 Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2029)
  • 5.3 Global Egg-Based Flu Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 6.2 Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2029)
  • 6.3 Global Egg-Based Flu Vaccines Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 7.2 North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 7.3 North America Egg-Based Flu Vaccines Market Size by Country
    • 7.3.1 North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 8.2 Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 8.3 Europe Egg-Based Flu Vaccines Market Size by Country
    • 8.3.1 Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Egg-Based Flu Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 10.2 South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 10.3 South America Egg-Based Flu Vaccines Market Size by Country
    • 10.3.1 South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Egg-Based Flu Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Egg-Based Flu Vaccines Market Drivers
  • 12.2 Egg-Based Flu Vaccines Market Restraints
  • 12.3 Egg-Based Flu Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Egg-Based Flu Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Egg-Based Flu Vaccines
  • 13.3 Egg-Based Flu Vaccines Production Process
  • 13.4 Egg-Based Flu Vaccines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Egg-Based Flu Vaccines Typical Distributors
  • 14.3 Egg-Based Flu Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Egg-Based Flu Vaccines. Industry analysis & Market Report on Egg-Based Flu Vaccines is a syndicated market report, published as Global Egg-Based Flu Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Egg-Based Flu Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo